{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:01:46Z","timestamp":1790226106083,"version":"4.1.0"},"reference-count":188,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Electrochemotherapy (ECT) is a locoregional treatment that combines poorly permeable drugs, commonly bleomycin (BLM) or cisplatin (CDDP), with electric pulses that induce electroporation. By transiently increasing cell membrane permeability, ECT promotes intracellular drug accumulation, enhancing cytotoxic effects while minimizing undesirable systemic toxicity. Beyond its direct cytotoxic effects, ECT exerts additional antitumour mechanisms that contribute to tumour control. These include the induction of immunogenic cell death (ICD), leading to activation of innate and adaptive immune responses; the \u201cabscopal effect\u201d, achieved with the combination of ECT and immune checkpoint inhibitors; and the \u201cvascular lock\u201d phenomenon, promoting a transient local blood flow reduction and enhancing intratumoural drug retention; and a \u201cvascular disrupting effect\u201d that contributes to tumour vascular damage and secondary tumour cell death. ECT has demonstrated high objective response rates (ORR) across a wide range of cutaneous malignancies, including melanoma and non-melanoma skin cancers (NMSCs) and cutaneous dissemination of other tumours. Although predictive biomarkers capable of identifying patients who benefit from treatment are still lacking, substantial preclinical and clinical evidence supports the efficacy, safety and tolerability of ECT. Several ongoing clinical trials are currently evaluating ECT, particularly in advanced or non-resecable melanoma, aiming to investigate further biological effects and optimize therapeutic strategies. Furthermore, innovative approaches integrating ECT with gene electrotransfer and nanomedicine represent a promising avenue to enhance its therapeutic efficacy and expand its role in precision oncology.<\/jats:p>","DOI":"10.3390\/ijms27198440","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:32:12Z","timestamp":1790083932000},"page":"8440","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advancing Electrochemotherapy in Melanoma and Non-Melanoma Skin Cancer: From Clinical Practice to Emerging Frontiers"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6640-7418","authenticated-orcid":false,"given":"Ramona","family":"Marrapodi","sequence":"first","affiliation":[{"name":"Laboratory of Cutaneous Physiopathology and Integrated Centre of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, Via Elio Chianesi 53, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4108-3104","authenticated-orcid":false,"given":"Arianna","family":"Presaghi","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, San Gallicano Dermatological Institute, IRCCS, Via Elio Chianesi 53, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5316-8937","authenticated-orcid":false,"given":"Emilia","family":"Migliano","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, San Gallicano Dermatological Institute, IRCCS, Via Elio Chianesi 53, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3883-5500","authenticated-orcid":false,"given":"Barbara","family":"Bellei","sequence":"additional","affiliation":[{"name":"Laboratory of Cutaneous Physiopathology and Integrated Centre of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, Via Elio Chianesi 53, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"ref_1","first-page":"8","article-title":"Electrochemotherapy in the treatment of melanoma","volume":"22","author":"Wichtowski","year":"2018","journal-title":"Contemp. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.clon.2019.08.010","article-title":"Electrochemotherapy and Ablative Therapies in Non-melanoma Skin Cancer","volume":"31","author":"Mowatt","year":"2019","journal-title":"Clin. Oncol. (R. Coll. Radiol)"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2340\/00015555-3341","article-title":"Electrochemotherapy in Skin Malignancies of Head and Neck Cancer Patients: Clinical Efficacy and Aesthetic Benefits","volume":"99","author":"Bonadies","year":"2019","journal-title":"Acta Derm.-Venereol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cpt.2024.08.002","article-title":"Overview of skin cancer types and prevalence rates across continents","volume":"3","author":"Roky","year":"2024","journal-title":"Cancer Pathog. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12943-023-01854-3","article-title":"Skin cancer: Understanding the journey of transformation from conventional to advanced treatment approaches","volume":"22","author":"Hasan","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Josiah, A.J., Twilley, D., Pillai, S.K., Ray, S.S., and Lall, N. (2021). Pathogenesis of Keratinocyte Carcinomas and the Therapeutic Potential of Medicinal Plants and Phytochemicals. Molecules, 26.","DOI":"10.3390\/molecules26071979"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Marrapodi, R., and Bellei, B. (2024). The Keratinocyte in the Picture Cutaneous Melanoma Microenvironment. Cancers, 16.","DOI":"10.3390\/cancers16050913"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/phpp.12329","article-title":"Mechanisms and prevention of UV-induced melanoma","volume":"34","author":"Sample","year":"2018","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.gendis.2014.08.005","article-title":"Ultraviolet radiation-induced non-melanoma skin cancer: Regulation of DNA damage repair and inflammation","volume":"1","author":"Kim","year":"2014","journal-title":"Genes Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2000027","DOI":"10.1002\/adtp.202000027","article-title":"Emerging technologies for local cancer treatment","volume":"3","author":"Chua","year":"2020","journal-title":"Adv. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.21873\/anticanres.14670","article-title":"Efficacy of Electrochemotherapy in the Treatment of Cutaneous Melanoma Metastases and Rare Non-melanoma Skin Cancer","volume":"40","author":"Borgognoni","year":"2020","journal-title":"Anticancer Res."},{"key":"ref_12","first-page":"91","article-title":"Electrochemotherapy for the Treatment of Unresectable Locoregionally Advanced Cutaneous Melanoma: A Systematic Review","volume":"108","year":"2017","journal-title":"Actas Dermosifiliogr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"118451","DOI":"10.1016\/j.biopha.2025.118451","article-title":"Cytotoxic agents for electrochemotherapy: Efficacy, mechanisms of action, potential candidates","volume":"191","author":"Morozas","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2478\/raon-2026-0030","article-title":"Tumor ablation: Emerging uses, challenges, and strategic implementation. A green paper by the Network of Expertise in Cancer (JANE-2), High Tech Medical Resources, network on Physical Methods of Tumor Ablation","volume":"60","author":"Gehl","year":"2026","journal-title":"Radiol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Condello, M., D\u2019Avack, G., Spugnini, E.P., and Meschini, S. (2022). Electrochemotherapy: An Alternative Strategy for Improving Therapy in Drug-Resistant SOLID Tumors. Cancers, 14.","DOI":"10.3390\/cancers14174341"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2784516","DOI":"10.1155\/2019\/2784516","article-title":"Electrochemotherapy: A Review of Current Status, Alternative IGP Approaches, and Future Perspectives","volume":"2019","author":"Esmaeili","year":"2019","journal-title":"J. Healthc. Eng."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1021\/bi00509a022","article-title":"Electric field induced transient pores in phospholipid bilayer vesicles","volume":"20","author":"Teissie","year":"1981","journal-title":"Biochemistry"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Tieleman, D.P. (2004). The molecular basis of electroporation. BMC Biochem., 5.","DOI":"10.1186\/1471-2091-5-10"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1365-201X.2003.01093.x","article-title":"Electroporation: Theory and methods, perspectives for drug delivery, gene therapy and research","volume":"177","author":"Gehl","year":"2003","journal-title":"Acta Physiol. Scand."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s11517-012-0991-8","article-title":"Electrochemotherapy: Technological advancements for efficient electroporation-based treatment of internal tumors","volume":"50","author":"Brecelj","year":"2012","journal-title":"Med. Biol. Eng. Comput."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0277-5379(91)90064-K","article-title":"Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses","volume":"27","author":"Mir","year":"1991","journal-title":"Eur. J. Cancer"},{"key":"ref_22","first-page":"3450","article-title":"Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice","volume":"55","author":"Sersa","year":"1995","journal-title":"Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0005-2736(94)90045-0","article-title":"Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin","volume":"1190","author":"Belehradek","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/0006-2952(91)90394-K","article-title":"Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture","volume":"42","author":"Poddevin","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"ref_25","first-page":"1815","article-title":"DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways","volume":"14","author":"Nelson","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00001813-199804000-00005","article-title":"Enhancement of cytotoxicity by electropermeabilization: An improved method for screening drugs","volume":"9","author":"Gehl","year":"1998","journal-title":"Anticancer Drugs"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00001813-200003000-00008","article-title":"Toxicity of anticancer agents mediated by electroporation in vitro","volume":"11","author":"Jaroszeski","year":"2000","journal-title":"Anticancer Drugs"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jconrel.2018.07.021","article-title":"Connecting the in vitro and in vivo experiments in electrochemotherapy\u2014A feasibility study modeling cisplatin transport in mouse melanoma using the dual-porosity model","volume":"286","author":"Vidmar","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0304-4165(96)00147-X","article-title":"In vivo antitumor effects of electrochemotherapy in a hepatoma model","volume":"1334","author":"Jaroszeski","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1002\/1097-0142(19931215)72:12<3694::AID-CNCR2820721222>3.0.CO;2-2","article-title":"Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial","volume":"72","author":"Belehradek","year":"1993","journal-title":"Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e046779","DOI":"10.1136\/bmjopen-2020-046779","article-title":"Study protocol designed to investigate tumour response to calcium electroporation in cancers affecting the skin: A non-randomised phase II clinical trial","volume":"11","author":"Vissing","year":"2021","journal-title":"BMJ Open"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"189319","DOI":"10.1016\/j.bbcan.2025.189319","article-title":"Advancing cancer therapy: Mechanisms, efficacy, and limitations of calcium electroporation","volume":"1880","author":"Szewczyk","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1038\/s41598-019-41188-z","article-title":"Calcium electroporation and electrochemotherapy for cancer treatment: Importance of cell membrane composition investigated by lipidomics, calorimetry and in vitro efficacy","volume":"9","author":"Hoejholt","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/0284186X.2017.1355109","article-title":"Calcium electroporation for treatment of cutaneous metastases; a randomized double-blinded phase II study, comparing the effect of calcium electroporation with electrochemotherapy","volume":"57","author":"Falk","year":"2018","journal-title":"Acta Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.bbagen.2013.12.003","article-title":"Calcium electroporation in three cell lines: A comparison of bleomycin and calcium, calcium compounds, and pulsing conditions","volume":"1840","author":"Frandsen","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Michel, O., Leke\u0161yt\u0117, B., Maly\u0161ko-Pta\u0161insk\u0117, V., Morozas, A., Malakauskait\u0117, P., Mickevi\u010di\u016bt\u0117-Zinkuvien\u0117, E., \u017delvys, A., Iva\u0161ka, J., Kulbacka, J., and Novickij, V. (2025). Application of nisin as a potential drug candidate for electrochemotherapy. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1689261"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Maly\u0161ko, V., Nemeikait\u0117-\u010c\u0117nien\u0117, A., Michel, O., Morozas, A., \u0141api\u0144ska, Z., Mickevi\u010di\u016bt\u0117-Zinkuvien\u0117, E., Malakauskait\u0117, P., \u017delvys, A., Leke\u0161yt\u0117, B., and Iva\u0161ka, J. (2026). Minimization of Cancellation Effect with Nisin During Bipolar Nanosecond Electrochemotherapy. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27104523"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.diii.2022.09.009","article-title":"Irreversible electroporation and electrochemotherapy in oncology: State of the art","volume":"103","author":"Tasu","year":"2022","journal-title":"Diagn. Interv. Imaging"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/bjr\/tqae231","article-title":"Reversible electroporation for cancer therapy","volume":"98","author":"Shiwani","year":"2025","journal-title":"Br. J. Radiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00262-015-1724-2","article-title":"Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer","volume":"64","author":"Sersa","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Gong, X., Chen, Z., Hu, J.J., and Liu, C. (2022). Advances of Electroporation-Related Therapies and the Synergy with Immunotherapy in Cancer Treatment. Vaccines, 10.","DOI":"10.3390\/vaccines10111942"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejcsup.2006.08.003","article-title":"Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes","volume":"4","author":"Mir","year":"2006","journal-title":"Eur. J. Cancer Suppl."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1080\/0284186X.2018.1454602","article-title":"Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases","volume":"57","author":"Gehl","year":"2018","journal-title":"Acta Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/0284186X.2022.2057199","article-title":"Electrochemotherapy for metastatic cutaneous melanoma","volume":"61","author":"Bastrup","year":"2022","journal-title":"Acta Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.annonc.2020.07.005","article-title":"ESMO consensus conference recommendations on the management of locoregional melanoma: Under the auspices of the ESMO Guidelines Committee","volume":"31","author":"Michielin","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1475-925X-13-29","article-title":"Electrochemotherapy: From the drawing board into medical practice","volume":"13","author":"Mali","year":"2014","journal-title":"Biomed. Eng. Online"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"107871","DOI":"10.1016\/j.bioelechem.2021.107871","article-title":"Cell death due to electroporation\u2014A review","volume":"141","year":"2021","journal-title":"Bioelectrochemistry"},{"key":"ref_48","first-page":"3","article-title":"Bleomycin pharmacology: Mechanism of action and resistance, and clinical pharmacokinetics","volume":"19","author":"Dorr","year":"1992","journal-title":"Semin. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e28131","DOI":"10.4161\/onci.28131","article-title":"Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells","volume":"3","author":"Calvet","year":"2014","journal-title":"OncoImmunology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/1878-0261.12851","article-title":"Targeting immunogenic cell death in cancer","volume":"14","author":"Ahmed","year":"2020","journal-title":"Mol. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.canlet.2018.11.015","article-title":"Electrochemotherapy with cisplatin increases survival and induces immunogenic responses in murine models of lung cancer and colorectal cancer","volume":"442","author":"Tremble","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Kesar, U., Markelc, B., Jesenko, T., Valentinuzzi, K.U., Cemazar, M., Strojan, P., and Sersa, G. (2023). Effects of Electrochemotherapy on Immunologically Important Modifications in Tumor Cells. Vaccines, 11.","DOI":"10.3390\/vaccines11050925"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"109263","DOI":"10.1016\/j.bioelechem.2026.109263","article-title":"Electrochemotherapy impacts the viability, functionality and phenotype of murine dendritic cells in voltage-dependent manner","volume":"170","author":"Bendix","year":"2026","journal-title":"Bioelectrochemistry"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.ejso.2022.05.023","article-title":"Electrochemotherapy and immune interactions; A boost to the system?","volume":"48","author":"Bendix","year":"2022","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.3748\/wjg.v11.i16.2426","article-title":"Effects and possible anti-tumor immunity of electrochemotherapy with bleomycin on human colon cancer xenografts in nude mice","volume":"11","author":"Zheng","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00001813-199609000-00011","article-title":"Electrochemotherapy with bleomycin in SA-1 tumor-bearing mice\u2014Natural resistance and immune responsiveness","volume":"7","author":"Sersa","year":"1996","journal-title":"Anticancer Drugs"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2147\/CCID.S115984","article-title":"Electrochemotherapy induces apoptotic death in melanoma metastases: A histologic and immunohistochemical investigation","volume":"9","author":"Bigi","year":"2016","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"6433","DOI":"10.3390\/curroncol31100478","article-title":"Clinical Insights and Future Prospects: A Comprehensive Narrative Review on Immunomodulation Induced by Electrochemotherapy","volume":"31","author":"Ferioli","year":"2024","journal-title":"Curr. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.ejso.2021.03.229","article-title":"Biological factors of the tumour response to electrochemotherapy: Review of the evidence and a research roadmap","volume":"47","author":"Sersa","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1755-148X.2011.00879.x","article-title":"FoxP3 expression on melanoma cells is related to early visceral spreading in melanoma patients treated by electrochemotherapy","volume":"24","author":"Quaglino","year":"2011","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10585-016-9814-x","article-title":"CD4(+)FOXP3(+) T regulatory cells decrease and CD3(+)CD8(+) T cells recruitment in TILs from melanoma metastases after electrochemotherapy","volume":"33","author":"Gerlini","year":"2016","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10585-012-9505-1","article-title":"Dendritic cells recruitment in melanoma metastasis treated by electrochemotherapy","volume":"30","author":"Gerlini","year":"2013","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Fang, K., Yuan, S., Zhang, X., Zhang, J., Sun, S.-L., and Li, X. (2025). Regulation of immunogenic cell death and potential applications in cancer therapy. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1571212"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Omerzel, M., Kranjc Brezar, S., Lampreht Tratar, L., Jesenko, T., Lisec, B., Sersa, G., and Cemazar, M. (2025). Potentiation of Electrochemotherapy by Anti-PD-1 Immunotherapy in Murine Tumors with Distinct Immune Profiles. Cancers, 18.","DOI":"10.3390\/cancers18010090"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s10585-025-10384-9","article-title":"Importance of the timing of combined electrochemotherapy and immunotherapy in the treatment of advanced melanoma","volume":"43","author":"Kis","year":"2025","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Campana, L.G., Peric, B., Mascherini, M., Spina, R., Kunte, C., Kis, E., Rozsa, P., Quaglino, P., Jones, R.P., and Clover, A.J.P. (2021). Combination of Pembrolizumab with Electrochemotherapy in Cutaneous Metastases from Melanoma: A Comparative Retrospective Study from the InspECT and Slovenian Cancer Registry. Cancers, 13.","DOI":"10.3390\/cancers13174289"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1109\/TBME.2022.3216869","article-title":"Study on B16 Cell Cytotoxicity by High Frequency Reversible Electroporation with Bleomycin That Induces Hallmarks of Immunogenic Death","volume":"70","author":"Lv","year":"2023","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1259\/0007-1285-26-305-234","article-title":"Whole body irradiation; radiobiology or medicine?","volume":"26","author":"Mole","year":"1953","journal-title":"Br. J. Radiol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Justesen, T.F., Orhan, A., Raskov, H., Nolsoe, C., and G\u00f6genur, I. (2022). Electroporation and Immunotherapy\u2014Unleashing the Abscopal Effect. Cancers, 14.","DOI":"10.3390\/cancers14122876"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Torchio, M., Cattaneo, L., Milione, M., Prinzi, N., Corti, F., Ungari, M., Anichini, A., Mortarini, R., Occhini, A., and Bertino, G. (2021). Case Report: Exceptional Response to Avelumab After Failure of Electrochemotherapy in a Patient With Rapidly Progressive, PD-L1-Negative Merkel Cell Carcinoma. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.628324"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Ruzgys, P., Navickait\u0117, D., Palep\u0161ien\u0117, R., U\u017edavinyt\u0117, D., Barauskait\u0117, N., Novickij, V., Girkontait\u0117, I., \u0160itkauskien\u0117, B., and \u0160atkauskas, S. (2022). Induction of Bystander and Abscopal Effects after Electroporation-Based Treatments. Cancers, 14.","DOI":"10.3390\/cancers14153770"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/sj.bjc.6600606","article-title":"Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin","volume":"87","author":"Sersa","year":"2002","journal-title":"Br. J. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0304-4165(01)00233-1","article-title":"Vascular reactions to in vivo electroporation: Characterization and consequences for drug and gene delivery","volume":"1569","author":"Gehl","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jconrel.2018.02.032","article-title":"Increased permeability of blood vessels after reversible electroporation is facilitated by alterations in endothelial cell-to-cell junctions","volume":"276","author":"Markelc","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Bogataj, J., Lampreht Tratar, U., Sersa, G., Cemazar, M., Groselj, A., and Omerzel, M. (2025). Effect of Bleomycin Hydrolase Expression in Tumor Tissue on the Therapeutic Effectiveness of Electrochemotherapy. Cancers, 18.","DOI":"10.3390\/cancers18010127"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s12010-021-03703-9","article-title":"Cisplatin-based Electrochemotherapy Significantly Downregulates Key Heat Shock Proteins in MDA-MB-231-Human Triple-Negative Breast Cancer Cells","volume":"194","author":"Sundararajan","year":"2021","journal-title":"Appl. Biochem. Biotechnol."},{"key":"ref_78","first-page":"3444","article-title":"Effect of electrochemotherapy with betulinic acid or cisplatin on regulation of heat shock proteins in metastatic human carcinoma cells in vitro","volume":"41","author":"Kutkowska","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_79","first-page":"e98402","article-title":"Clinical Effectiveness and Safety of Electrochemotherapy (ECT) in the Treatment of Locally Advanced Melanoma: A Systematic Review","volume":"17","author":"Vickars","year":"2025","journal-title":"Cureus"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10585-022-10180-9","article-title":"Electrochemotherapy of skin metastases from malignant melanoma: A PRISMA-compliant systematic review","volume":"39","author":"Ferioli","year":"2022","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/bjd.15340","article-title":"Electrochemotherapy in the treatment of metastatic malignant melanoma: A prospective cohort study by InspECT","volume":"176","author":"Kunte","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"108629","DOI":"10.1016\/j.bioelechem.2023.108629","article-title":"Therapeutic perspectives of high pulse repetition rate electroporation","volume":"156","author":"Talmont","year":"2024","journal-title":"Bioelectrochemistry"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejcsup.2006.08.002","article-title":"Electrochemotherapy\u2014An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study","volume":"4","author":"Marty","year":"2006","journal-title":"Eur. J. Cancer Suppl."},{"key":"ref_84","first-page":"308","article-title":"Electrochemotherapy in advanced skin tumors and cutaneous metastases\u2014A retrospective multicenter analysis","volume":"13","author":"Kreuter","year":"2015","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.21873\/anticanres.15139","article-title":"Neurological Complications After Electrochemotherapy Treatment in the Head and Neck Area","volume":"41","author":"Kristiansson","year":"2021","journal-title":"Anticancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"9790","DOI":"10.1074\/jbc.M212929200","article-title":"Malignant transformation of melanocytes to melanoma by constitutive activation of mitogen-activated protein kinase kinase (MAPKK) signaling","volume":"278","author":"Govindarajan","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"7","DOI":"10.14740\/wjon1349","article-title":"Cutaneous Malignant Melanoma: A Review of Early Diagnosis and Management","volume":"12","author":"Naik","year":"2021","journal-title":"World J. Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e2021162S","DOI":"10.5826\/dpc.11S1a162S","article-title":"Melanoma: Staging and Follow-Up","volume":"11","author":"Papageorgiou","year":"2021","journal-title":"Dermatol. Pract. Concept"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1001\/jama.2025.13074","article-title":"Cutaneous Melanoma: A Review","volume":"334","author":"Joshi","year":"2025","journal-title":"JAMA"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","article-title":"Cutaneous melanoma","volume":"402","author":"Long","year":"2023","journal-title":"Lancet"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Criado-Otero, M., Navedo-de Las Heras, M., and Samaniego-Gonz\u00e1lez, E. (2024). Topical and Intralesional Treatments for Skin Metastases and Locoregionally Advanced Melanoma. Cancers, 17.","DOI":"10.3390\/cancers17010067"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2478\/raon-2019-0025","article-title":"The use of high-frequency short bipolar pulses in cisplatin electrochemotherapy in vitro","volume":"53","author":"Scuderi","year":"2019","journal-title":"Radiol. Oncol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"18039","DOI":"10.1038\/s41598-022-22874-x","article-title":"Pulse width and intensity effects of pulsed electric fields on cancerous and normal skin cells","volume":"12","author":"Rao","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bioelechem.2017.09.009","article-title":"Comparable effectiveness and immunomodulatory actions of oxaliplatin and cisplatin in electrochemotherapy of murine melanoma","volume":"119","author":"Ursic","year":"2018","journal-title":"Bioelectrochemistry"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1515\/raon-2016-0042","article-title":"Electrochemotherapy with bleomycin is effective in BRAF mutated melanoma cells and interacts with BRAF inhibitors","volume":"50","author":"Dolinsek","year":"2016","journal-title":"Radiol. Oncol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Fiorentzis, M., Viestenz, A., Siebolts, U., Seitz, B., Coupland, S.E., and Heinzelmann, J. (2019). The Potential Use of Electrochemotherapy in the Treatment of Uveal Melanoma: In Vitro Results in 3D Tumor Cultures and In Vivo Results in a Chick Embryo Model. Cancers, 11.","DOI":"10.3390\/cancers11091344"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"E632","DOI":"10.1111\/aos.13993","article-title":"Conjunctival melanoma and electrochemotherapy: Preliminary results using 2D and 3D cell culture models in vitro","volume":"97","author":"Fiorentzis","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Fiorentzis, M., Sokolenko, E.A., Bechrakis, N.E., Ting, S., Schmid, K.W., Sak, A., Stuschke, M., Seitz, B., and Berchner-Pfannschmidt, U. (2021). Electrochemotherapy with Bleomycin Enhances Radiosensitivity of Uveal Melanomas: First In Vitro Results in 3D Cultures of Primary Uveal Melanoma Cell Lines. Cancers, 13.","DOI":"10.3390\/cancers13123086"},{"key":"ref_99","first-page":"e60611","article-title":"Electrochemotherapy in 3D Ocular Melanoma Spheroids using a Customized Electrode","volume":"158","author":"Fiorentzis","year":"2020","journal-title":"J. Vis. Exp."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"108624","DOI":"10.1016\/j.bioelechem.2023.108624","article-title":"Development of 3D melanoma cultures on a hyaluronic acid-based scaffold with synthetic self-assembling peptides: Electroporation enhancement","volume":"156","author":"Zamuner","year":"2024","journal-title":"Bioelectrochemistry"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00232-014-9696-2","article-title":"Modulation of activity of known cytotoxic ruthenium(III) compound (KP418) with hampered transmembrane transport in electrochemotherapy in vitro and in vivo","volume":"247","author":"Hudej","year":"2014","journal-title":"J. Membr. Biol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bioelechem.2007.05.002","article-title":"Combined therapy of the antimetastatic compound NAMI-A and electroporation on B16F1 tumour cells in vitro","volume":"71","author":"Bicek","year":"2007","journal-title":"Bioelectrochemistry"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1089\/bioe.2023.0041","article-title":"The Efficacy of Electrochemotherapy with Dacarbazine on Melanoma Cells","volume":"6","author":"Coskun","year":"2024","journal-title":"Bioelectricity"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00008390-199702000-00003","article-title":"Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy","volume":"7","author":"Heller","year":"1997","journal-title":"Melanoma Res."},{"key":"ref_105","first-page":"3190","article-title":"Tumor growth retardation, cure, and induction of antitumor immunity in B16 melanoma-bearing mice by low electric field-enhanced chemotherapy","volume":"9","author":"Entin","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00008390-200012000-00010","article-title":"In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity","volume":"10","author":"Heller","year":"2000","journal-title":"Melanoma Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ymthe.2006.06.010","article-title":"Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation","volume":"14","author":"McCray","year":"2006","journal-title":"Mol. Ther."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1007\/s10439-006-9151-3","article-title":"Electric fields in tumors exposed to external voltage sources: Implication for electric field-mediated drug and gene delivery","volume":"34","author":"Mossop","year":"2006","journal-title":"Ann. Biomed. Eng."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Lisec, B., Markelc, B., Ursic Valentinuzzi, K., Sersa, G., and Cemazar, M. (2023). The effectiveness of calcium electroporation combined with gene electrotransfer of a plasmid encoding IL-12 is tumor type-dependent. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1189960"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1515\/raon-2016-0014","article-title":"Electrochemotherapy by pulsed electromagnetic field treatment (PEMF) in mouse melanoma B16F10 in vivo","volume":"50","author":"Kranjc","year":"2016","journal-title":"Radiol. Oncol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/archderm.1996.03890350095015","article-title":"Bleomycin-mediated electrochemotherapy of metastatic melanoma","volume":"132","author":"Glass","year":"1996","journal-title":"Arch. Dermatol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/(SICI)1097-0142(19960301)77:5<964::AID-CNCR24>3.0.CO;2-0","article-title":"Phase I\/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy","volume":"77","author":"Heller","year":"1996","journal-title":"Cancer"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1038\/bjc.1998.388","article-title":"Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy","volume":"77","author":"Mir","year":"1998","journal-title":"Br. J. Cancer"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0959-8049(98)00025-2","article-title":"Electrochemotherapy with cisplatin: Potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients","volume":"34","author":"Rudolf","year":"1998","journal-title":"Eur. J. Cancer"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0188-4409(01)00278-8","article-title":"Electrochemotherapy in primary and metastatic skin tumors: Phase II trial using intralesional bleomycin","volume":"32","year":"2001","journal-title":"Arch. Med. Res."},{"key":"ref_116","first-page":"863","article-title":"Electrochemotherapy with cisplatin: Clinical experience in malignant melanoma patients","volume":"6","author":"Sersa","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/00008390-200010000-00009","article-title":"Electrochemotherapy of cutaneous metastases in malignant melanoma","volume":"10","author":"Rols","year":"2000","journal-title":"Melanoma Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00008390-200012000-00011","article-title":"Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy","volume":"10","author":"Gehl","year":"2000","journal-title":"Melanoma Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3109\/0284186X.2011.573626","article-title":"Management of cutaneous metastases using electrochemotherapy","volume":"50","author":"Matthiessen","year":"2011","journal-title":"Acta Oncol."},{"key":"ref_120","first-page":"285","article-title":"Electrochemotherapy in the treatment of melanoma skin metastases: A report on 31 cases","volume":"106","author":"Vilalta","year":"2015","journal-title":"Actas Dermo-Sifiliogr."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1245\/s10434-008-9976-0","article-title":"Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases","volume":"15","author":"Quaglino","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1245\/s10434-008-0204-8","article-title":"Bleomycin-based electrochemotherapy: Clinical outcome from a single institution\u2019s experience with 52 patients","volume":"16","author":"Campana","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jso.23481","article-title":"Electrochemotherapy for the management of cutaneous and subcutaneous metastasis: A series of 39 patients treated with palliative intent","volume":"109","author":"Solari","year":"2014","journal-title":"J. Surg. Oncol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/dth.12098","article-title":"Electrochemotherapy: An effective local treatment of cutaneous and subcutaneous melanoma metastases","volume":"27","author":"Ricotti","year":"2014","journal-title":"Dermatol. Ther."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0190-9622(97)70178-6","article-title":"Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma","volume":"37","author":"Glass","year":"1997","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/ijd.17346","article-title":"The role of electrochemotherapy in the treatment of locally advanced or recurrent eyelid-periocular basal cell carcinoma: Long-term results","volume":"64","author":"Vass","year":"2024","journal-title":"Int. J. Dermatol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"648","DOI":"10.2340\/00015555-1361","article-title":"Successful treatment of multiple basaliomas with bleomycin-based electrochemotherapy: A case series of three patients with Gorlin-Goltz syndrome","volume":"92","author":"Kis","year":"2012","journal-title":"Acta Derm.-Venereol."},{"key":"ref_128","first-page":"95","article-title":"Electrochemotherapy in Gorlin-Goltz syndrome","volume":"156","author":"Miraglia","year":"2021","journal-title":"Ital. J. Dermatol. Venereol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2478\/raon-2025-0040","article-title":"Electrochemotherapy for basal cell carcinoma in the head and neck region: 5-year follow-up from the Insp-ECT registry","volume":"59","author":"Groselj","year":"2025","journal-title":"Radiol. Oncol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12967-017-1225-5","article-title":"Basal cell carcinoma: 10-year experience with electrochemotherapy","volume":"15","author":"Campana","year":"2017","journal-title":"J. Transl. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ejso.2019.11.509","article-title":"Electrochemotherapy for the treatment of primary basal cell carcinoma; A randomised control trial comparing electrochemotherapy and surgery with five year follow up","volume":"46","author":"Clover","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejca.2016.05.001","article-title":"European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results of the treatment of skin cancer","volume":"63","author":"Bertino","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"7037657","DOI":"10.1155\/dth\/7037657","article-title":"Electrochemotherapy for Multiple Nonmelanoma Skin Tumors in Immunosuppressed Patients: A Prospective Cohort Analysis","volume":"2025","author":"Papp","year":"2025","journal-title":"Dermatol. Ther."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"101365","DOI":"10.1016\/j.bjorl.2023.101365","article-title":"Effectiveness and tolerance of electrochemotherapy as palliative therapy for patients with head and neck cancer and malignant melanoma and its relation to early skin reaction","volume":"90","author":"Coll","year":"2024","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e14093","DOI":"10.1111\/dth.14093","article-title":"Electrochemotherapy, a local treatment for squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa","volume":"33","author":"Bartolo","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0190-9622(96)90838-5","article-title":"Bleomycin-mediated electrochemotherapy of basal cell carcinoma","volume":"34","author":"Glass","year":"1996","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/(SICI)1097-0142(19980701)83:1<148::AID-CNCR20>3.0.CO;2-W","article-title":"Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin","volume":"83","author":"Heller","year":"1998","journal-title":"Cancer"},{"key":"ref_138","first-page":"e13547","article-title":"The use of cisplatin electrochemotherapy in nonmelanoma skin cancers: A single-center study","volume":"33","author":"Saqer","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/archderm.144.9.1186","article-title":"Metastatic basal cell carcinoma with squamous differentiation: Report of a case with response of cutaneous metastases to electrochemotherapy","volume":"144","author":"Fantini","year":"2008","journal-title":"Arch. Dermatol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.ejso.2016.06.399","article-title":"Treatment efficacy with electrochemotherapy: A multi-institutional prospective observational study on 376 patients with superficial tumors","volume":"42","author":"Campana","year":"2016","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/030089161209800305","article-title":"Electrochemotherapy for the treatment of recurrent head and neck cancers: Preliminary results","volume":"98","author":"Mevio","year":"2012","journal-title":"Tumori J."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"15330338251338635","DOI":"10.1177\/15330338251338635","article-title":"Electrochemotherapy for Recurrence and\/or Metastatic Skin Cancers: A Prospective Case Series in Iran","volume":"24","author":"YazdanParast","year":"2025","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/00016489.2018.1543950","article-title":"Long-term follow-up in patients treated with electrochemotherapy for non-melanoma skin cancer in the head and neck area","volume":"139","author":"Kristiansson","year":"2019","journal-title":"Acta Otolaryngol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2478\/raon-2020-0009","article-title":"Long term response of electrochemotherapy with reduced dose of bleomycin in elderly patients with head and neck non-melanoma skin cancer","volume":"54","author":"Jamsek","year":"2020","journal-title":"Radiol. Oncol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hed.24991","article-title":"Efficiency of electrochemotherapy with reduced bleomycin dose in the treatment of nonmelanoma head and neck skin cancer: Preliminary results","volume":"40","author":"Groselj","year":"2018","journal-title":"Head Neck"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/jdv.14708","article-title":"Electrochemotherapy of unresectable cutaneous tumours with reduced dosages of intravenous bleomycin: Analysis of 57 patients from the International Network for Sharing Practices of Electrochemotherapy registry","volume":"32","author":"Rotunno","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejca.2020.06.020","article-title":"Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008\u20132019)","volume":"138","author":"Clover","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"100330","DOI":"10.1016\/j.omsc.2023.100330","article-title":"Synergy of electrochemotherapy and immunotherapy in the treatment of skin squamous cell carcinoma of the head and neck","volume":"9","author":"Barca","year":"2023","journal-title":"Oral Maxillofac. Surg. Cases"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00008390-200008000-00010","article-title":"Electrochemotherapy with cisplatin: The systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases","volume":"10","author":"Rudolf","year":"2000","journal-title":"Melanoma Res."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12967-017-1186-8","article-title":"Electrochemotherapy efficacy evaluation for treatment of locally advanced stage III cutaneous squamous cell carcinoma: A 22-cases retrospective analysis","volume":"15","author":"Simeone","year":"2017","journal-title":"J. Transl. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1038\/s41598-025-90485-3","article-title":"Global, regional, and national trends in the burden of melanoma and non-melanoma skin cancer: Insights from the global burden of disease study 1990\u20132021","volume":"15","author":"Zhou","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Chedid, M.F., Tregnago, A.C., Riva, F., Prediger, L., Agarwal, A., and Mattei, J. (2025). Indications and Mechanisms of Action of the Main Treatment Modalities for Non-Melanoma Skin Cancer. Life, 15.","DOI":"10.3390\/life15091447"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"116763","DOI":"10.1016\/j.ejca.2026.116763","article-title":"European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention\u2014Update 2026","volume":"243","author":"Stratigos","year":"2026","journal-title":"Eur. J. Cancer"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Campana, L.G., Daud, A., Lancellotti, F., Arroyo, J.P., Davalos, R.V., Di Prata, C., and Gehl, J. (2023). Pulsed Electric Fields in Oncology: A Snapshot of Current Clinical Practices and Research Directions from the 4th World Congress of Electroporation. Cancers, 15.","DOI":"10.3390\/cancers15133340"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccell.2017.12.015","article-title":"Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma","volume":"33","author":"Eberl","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"adv19678","DOI":"10.2340\/actadv.v104.19678","article-title":"An Explorative Study on Calcium Electroporation for Low-risk Basal Cell Carcinoma","volume":"104","author":"Wiegell","year":"2024","journal-title":"Acta Derm.-Venereol."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Frandsen, S.K., Vissing, M., and Gehl, J. (2020). A Comprehensive Review of Calcium Electroporation\u2014A Novel Cancer Treatment Modality. Cancers, 12.","DOI":"10.3390\/cancers12020290"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1080\/0284186X.2017.1290274","article-title":"Electrochemotherapy and calcium electroporation inducing a systemic immune response with local and distant remission of tumors in a patient with malignant melanoma\u2014A case report","volume":"56","author":"Falk","year":"2017","journal-title":"Acta Oncol."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Frandsen, S.K., Gibot, L., Madi, M., Gehl, J., and Rols, M.-P. (2015). Calcium Electroporation: Evidence for Differential Effects in Normal and Malignant Cell Lines, Evaluated in a 3D Spheroid Model. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0144028"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Condello, M., D\u2019avack, G., Vona, R., Spugnini, E.P., Scacco, L., and Meschini, S. (2021). Electrochemotherapy with Mitomycin C Potentiates Apoptosis Death by Inhibiting Autophagy in Squamous Carcinoma Cells. Cancers, 13.","DOI":"10.3390\/cancers13153867"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Yin, D., Yang, W.G., Weissberg, J., Goff, C.B., Chen, W., Kuwayama, Y., Leiter, A., Xing, H., Meixel, A., and Gaut, D. (2012). Cutaneous papilloma and squamous cell carcinoma therapy utilizing nanosecond pulsed electric fields (nsPEF). PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043891"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2217\/fon.13.235","article-title":"Locally enhanced chemotherapy by electroporation: Clinical experiences and perspective of use of electrochemotherapy","volume":"10","author":"Cadossi","year":"2014","journal-title":"Future Oncol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1586\/era.10.43","article-title":"Antivascular effects of electrochemotherapy: Implications in treatment of bleeding metastases","volume":"10","author":"Jarm","year":"2010","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2013.01.021","article-title":"Antitumor drug delivery in multicellular spheroids by electropermeabilization","volume":"167","author":"Gibot","year":"2013","journal-title":"J. Control. Release"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Tan, Y.T.N., and Oh, C.C. (2025). Electrochemotherapy in the Management of Keratinocyte Carcinomas: A Systematic Review. Cancers, 17.","DOI":"10.3390\/cancers17111766"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1007\/s12094-024-03522-4","article-title":"Treatment benefit of electrochemotherapy for superficial squamous cell carcinoma: A systematic review and single-arm meta-analysis","volume":"26","author":"Wu","year":"2024","journal-title":"Clin. Transl. Oncol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0169-409X(97)00034-3","article-title":"Electrochemotherapy: An emerging drug delivery method for the treatment of cancer","volume":"26","author":"Heller","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1200\/JCO.2007.15.6794","article-title":"Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma","volume":"26","author":"Daud","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1158\/2326-6066.CIR-19-0359","article-title":"Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses","volume":"8","author":"Greaney","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1158\/1078-0432.CCR-19-2217","article-title":"Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma","volume":"26","author":"Algazi","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2051-1426-1-20","article-title":"Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma","volume":"1","author":"Yuan","year":"2013","journal-title":"J. Immunother. Cancer"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1039\/C9TB02470K","article-title":"Development of functional liposomes by modification of stimuli-responsive materials and their biomedical applications","volume":"8","author":"Yuba","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1039\/C7TB00038C","article-title":"Electroporation for nanomedicine: A review","volume":"5","author":"Kim","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Pisani, S., Bertino, G., Prina-Mello, A., Locati, L.D., Mauramati, S., Genta, I., Dorati, R., Conti, B., and Benazzo, M. (2022). Electroporation in Head-and-Neck Cancer: An Innovative Approach with Immunotherapy and Nanotechnology Combination. Cancers, 14.","DOI":"10.3390\/cancers14215363"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbrc.2015.08.022","article-title":"Magnetic nanoparticle-based drug delivery for cancer therapy","volume":"468","author":"Tietze","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"108999","DOI":"10.1016\/j.bioelechem.2025.108999","article-title":"Improving bleomycin electrochemotherapy with gold nanoparticles: First in vivo study on intra-tumoral field amplification","volume":"165","author":"German","year":"2025","journal-title":"Bioelectrochemistry"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Tian, L., Wang, L., Qiao, Y., Lu, L., Lee, P., Chang, A., Ravi, S., Rogers, T.A., and Melancon, M.P. (2019). Antitumor Efficacy of Liposome-Encapsulated NVP-BEZ235 Combined with Irreversible Electroporation for Head and Neck Cancer. Molecules, 24.","DOI":"10.3390\/molecules24193560"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Li, D., Liang, H., Lan, B., Chang, P., Yang, Y., Cheng, Y., Li, G., and Lu, H. (2025). Recent Progress of Magnetic Nanomaterials with Enhanced Enzymatic Activities in Antitumor Therapy. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262210890"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/08853282221087416","article-title":"Noninvasive remote-controlled nanomedicine by using electric field stimulation for in vivo effective cancer therapy","volume":"37","author":"Liu","year":"2022","journal-title":"J. Biomater. Appl."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1038\/srep02953","article-title":"Magneto-electric nanoparticles to enable field-controlled high-specificity drug delivery to eradicate ovarian cancer cells","volume":"3","author":"Guduru","year":"2013","journal-title":"Sci. Rep."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5603\/FHC.a2019.0018","article-title":"In vitro evaluation of electroporated gold nanoparticles and extremely-low frequency electromagnetic field anticancer activity against Hep-2 laryngeal cancer cells","volume":"57","author":"Alshehri","year":"2019","journal-title":"Folia Histochem. Cytobiol."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Leke\u0161yt\u0117, B., Mickevi\u010di\u016bt\u0117, E., Malakauskait\u0117, P., Szewczyk, A., Radzevi\u010di\u016bt\u0117-Val\u010diuk\u0117, E., Maly\u0161ko-Pta\u0161insk\u0117, V., \u017delvys, A., German, N., Ramanavi\u010dien\u0117, A., and Kulbacka, J. (2024). Application of Gold Nanoparticles for Improvement of Electroporation-Assisted Drug Delivery and Bleomycin Electrochemotherapy. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16101278"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Bonferoni, M.C., Rassu, G., Gavini, E., Sorrenti, M., Catenacci, L., Torre, M.L., Perteghella, S., Ansaloni, L., Maestri, M., and Giunchedi, P. (2021). Electrochemotherapy of Deep-Seated Tumors: State of Art and Perspectives as Possible \u201cEPR Effect Enhancer\u201d to Improve Cancer Nanomedicine Efficacy. Cancers, 13.","DOI":"10.3390\/cancers13174437"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1148\/radiol.2017161721","article-title":"Development of an Electroporation and Nanoparticle-based Therapeutic Platform for Bone Metastases","volume":"286","author":"Melancon","year":"2018","journal-title":"Radiology"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"9895","DOI":"10.3390\/curroncol30110719","article-title":"Combination of Electrochemotherapy with Radiotherapy: A Comprehensive, Systematic, PRISMA-Compliant Review of Efficacy and Potential Radiosensitizing Effects in Tumor Control","volume":"30","author":"Ferioli","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Bonadies, A., Iorio, A., Silipo, V., Cota, C., Govoni, F.A., Battista, M., Pallara, T., and Migliano, E. (2023). Bleomycin Electrochemotherapy of Dermal Cylindroma as an Alternative Treatment in a Rare Adnexal Neoplasm: A Case Report and Literature Review. Biomedicines, 11.","DOI":"10.3390\/biomedicines11102667"},{"key":"ref_187","first-page":"6121","article-title":"Electrochemotherapy of a Multirecurrent Dermatofibrosarcoma Protuberans of the Orbital Margin: A Case Report","volume":"35","author":"Bonadies","year":"2015","journal-title":"Anticancer Res."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/ijd.16261","article-title":"Cutaneous and subcutaneous Kaposi\u2019s sarcoma lesions treated with electrochemotherapy","volume":"62","author":"Lalanda","year":"2023","journal-title":"Int. J. Dermatol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8440\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:26:18Z","timestamp":1790223978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":188,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["ijms27198440"],"URL":"https:\/\/doi.org\/10.3390\/ijms27198440","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]}}}